The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Fuca G;Guarini V;Antoniotti C;Morano F;Moretto R;Corallo S;Marmorino F;Lonardi S;Rimassa L;Sartore-Bianchi A;Borelli B;Tampellini M;Bustreo S;Claravezza M;Boccaccino A;Murialdo R;Zaniboni A;Tomasello G;Loupakis F;Adamo V;Tonini G;Cortesi E;de Braucl F;Cremolini C;Pietrantonio F

2020-01-01